BioCentury
ARTICLE | Clinical News

Macrilen macimorelin acetate regulatory update

November 24, 2014 8:00 AM UTC

FDA issued a complete response letter for Macrilen macimorelin from Aeterna Zentaris for use in evaluating adult growth hormone deficiency (AGHD). According to Aeterna Zentaris, FDA said the company’s...